Monsanto India shares down 4%, hit 52-week low

PTI Mumbai | Updated on January 20, 2018

Shares of agri-biotechnology major Monsanto India fell by 4 per cent today after fair trade regulator CCI ordered a detailed probe against its US-parent joint venture Mahyco Monsanto Biotech India Ltd (MMBL).

Finding prima-facie violation of the competition law, CCI has ordered a detailed probe into alleged abuse of dominance by the Indian arm of the US-based genetically modified seed giant Monsanto.

The stock fell by 3.99 per cent to Rs 1,900.20 — its 52-week low — on the BSE.

On NSE, it slipped 3.37 per cent to hit a one-year low of Rs 1,910.

The majority order passed by six out of seven members including Chairman of the Competition Commission, follows two separate complaints filed against Mahyco Monsanto Biotech India Ltd (MMBL) — one by the Agriculture Ministry and another by three domestic seed companies — alleging abuse of dominance in the country’s Bt cotton seeds market.

The ministry had referred to the Competition Commission of India complaints filed against MMBL, including about “abuse of dominant position by charging unreasonably high trait fees (royalty) for Bt cotton seeds”.

Mahyco Monsato Biotech has said it will cooperate with the investigation by CCI and expressed confidence that the allegation against the company relating to abuse of dominance would be “ultimately dismissed”.

MMBL is a 50-50 joint venture between Monsanto and Mahyco.

Monsanto India is a subsidiary of US-based Monsanto, engaged in selling agri-inputs.

Published on February 18, 2016

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor